nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP2D6—Fingolimod—multiple sclerosis	0.145	0.261	CbGbCtD
Darifenacin—CYP3A4—Fingolimod—multiple sclerosis	0.0924	0.166	CbGbCtD
Darifenacin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0596	0.107	CbGbCtD
Darifenacin—CYP3A4—Triamcinolone—multiple sclerosis	0.0451	0.081	CbGbCtD
Darifenacin—CYP3A4—Mitoxantrone—multiple sclerosis	0.0434	0.078	CbGbCtD
Darifenacin—CYP3A4—Betamethasone—multiple sclerosis	0.0387	0.0695	CbGbCtD
Darifenacin—CYP3A4—Prednisolone—multiple sclerosis	0.0382	0.0686	CbGbCtD
Darifenacin—CYP3A4—Prednisone—multiple sclerosis	0.0361	0.0648	CbGbCtD
Darifenacin—CYP2D6—Dexamethasone—multiple sclerosis	0.0354	0.0636	CbGbCtD
Darifenacin—CYP3A4—Dexamethasone—multiple sclerosis	0.0225	0.0404	CbGbCtD
Darifenacin—Loperamide—POMC—multiple sclerosis	0.00287	1	CrCbGaD
Darifenacin—Vision blurred—Prednisolone—multiple sclerosis	0.000736	0.00204	CcSEcCtD
Darifenacin—Visual impairment—Betamethasone—multiple sclerosis	0.000722	0.002	CcSEcCtD
Darifenacin—Visual impairment—Dexamethasone—multiple sclerosis	0.000722	0.002	CcSEcCtD
Darifenacin—Mental disorder—Methylprednisolone—multiple sclerosis	0.000721	0.002	CcSEcCtD
Darifenacin—Angioedema—Prednisolone—multiple sclerosis	0.000714	0.00198	CcSEcCtD
Darifenacin—Breast disorder—Methotrexate—multiple sclerosis	0.000712	0.00197	CcSEcCtD
Darifenacin—Hypersensitivity—Azathioprine—multiple sclerosis	0.000708	0.00196	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000708	0.00196	CcSEcCtD
Darifenacin—Dysgeusia—Triamcinolone—multiple sclerosis	0.000704	0.00195	CcSEcCtD
Darifenacin—Nausea—Cladribine—multiple sclerosis	0.000702	0.00195	CcSEcCtD
Darifenacin—Syncope—Prednisolone—multiple sclerosis	0.000701	0.00194	CcSEcCtD
Darifenacin—Eye disorder—Betamethasone—multiple sclerosis	0.0007	0.00194	CcSEcCtD
Darifenacin—Eye disorder—Dexamethasone—multiple sclerosis	0.0007	0.00194	CcSEcCtD
Darifenacin—Back pain—Triamcinolone—multiple sclerosis	0.000695	0.00192	CcSEcCtD
Darifenacin—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000693	0.00192	CcSEcCtD
Darifenacin—Somnolence—Mitoxantrone—multiple sclerosis	0.000691	0.00191	CcSEcCtD
Darifenacin—Loss of consciousness—Prednisolone—multiple sclerosis	0.000687	0.0019	CcSEcCtD
Darifenacin—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000684	0.00189	CcSEcCtD
Darifenacin—Angiopathy—Betamethasone—multiple sclerosis	0.000679	0.00188	CcSEcCtD
Darifenacin—Angiopathy—Dexamethasone—multiple sclerosis	0.000679	0.00188	CcSEcCtD
Darifenacin—Hypertension—Prednisolone—multiple sclerosis	0.000675	0.00187	CcSEcCtD
Darifenacin—Constipation—Mitoxantrone—multiple sclerosis	0.000665	0.00184	CcSEcCtD
Darifenacin—Pain—Mitoxantrone—multiple sclerosis	0.000665	0.00184	CcSEcCtD
Darifenacin—Diarrhoea—Azathioprine—multiple sclerosis	0.000658	0.00182	CcSEcCtD
Darifenacin—Angioedema—Triamcinolone—multiple sclerosis	0.000656	0.00182	CcSEcCtD
Darifenacin—Angioedema—Methylprednisolone—multiple sclerosis	0.000655	0.00181	CcSEcCtD
Darifenacin—Hallucination—Prednisone—multiple sclerosis	0.000649	0.0018	CcSEcCtD
Darifenacin—Syncope—Triamcinolone—multiple sclerosis	0.000644	0.00178	CcSEcCtD
Darifenacin—Syncope—Methylprednisolone—multiple sclerosis	0.000643	0.00178	CcSEcCtD
Darifenacin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00064	0.00177	CcSEcCtD
Darifenacin—Oedema—Prednisolone—multiple sclerosis	0.000638	0.00177	CcSEcCtD
Darifenacin—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000638	0.00177	CcSEcCtD
Darifenacin—Dizziness—Azathioprine—multiple sclerosis	0.000636	0.00176	CcSEcCtD
Darifenacin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000636	0.00176	CcSEcCtD
Darifenacin—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000631	0.00175	CcSEcCtD
Darifenacin—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00063	0.00174	CcSEcCtD
Darifenacin—Shock—Prednisolone—multiple sclerosis	0.000627	0.00174	CcSEcCtD
Darifenacin—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000627	0.00174	CcSEcCtD
Darifenacin—Cough—Triamcinolone—multiple sclerosis	0.000627	0.00174	CcSEcCtD
Darifenacin—Tachycardia—Prednisolone—multiple sclerosis	0.000622	0.00172	CcSEcCtD
Darifenacin—Hypertension—Triamcinolone—multiple sclerosis	0.00062	0.00172	CcSEcCtD
Darifenacin—Hypertension—Methylprednisolone—multiple sclerosis	0.000619	0.00171	CcSEcCtD
Darifenacin—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000616	0.00171	CcSEcCtD
Darifenacin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000614	0.0017	CcSEcCtD
Darifenacin—Vomiting—Azathioprine—multiple sclerosis	0.000611	0.00169	CcSEcCtD
Darifenacin—Arthralgia—Methylprednisolone—multiple sclerosis	0.00061	0.00169	CcSEcCtD
Darifenacin—Eye disorder—Prednisone—multiple sclerosis	0.000609	0.00169	CcSEcCtD
Darifenacin—Infestation NOS—Methotrexate—multiple sclerosis	0.000607	0.00168	CcSEcCtD
Darifenacin—Infestation—Methotrexate—multiple sclerosis	0.000607	0.00168	CcSEcCtD
Darifenacin—Rash—Azathioprine—multiple sclerosis	0.000606	0.00168	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000606	0.00168	CcSEcCtD
Darifenacin—Dermatitis—Azathioprine—multiple sclerosis	0.000606	0.00168	CcSEcCtD
Darifenacin—Headache—Azathioprine—multiple sclerosis	0.000602	0.00167	CcSEcCtD
Darifenacin—Dry mouth—Triamcinolone—multiple sclerosis	0.000598	0.00166	CcSEcCtD
Darifenacin—Angioedema—Betamethasone—multiple sclerosis	0.000596	0.00165	CcSEcCtD
Darifenacin—Angioedema—Dexamethasone—multiple sclerosis	0.000596	0.00165	CcSEcCtD
Darifenacin—Stomatitis—Methotrexate—multiple sclerosis	0.000592	0.00164	CcSEcCtD
Darifenacin—Angiopathy—Prednisone—multiple sclerosis	0.000592	0.00164	CcSEcCtD
Darifenacin—Confusional state—Methylprednisolone—multiple sclerosis	0.00059	0.00163	CcSEcCtD
Darifenacin—Oedema—Triamcinolone—multiple sclerosis	0.000586	0.00162	CcSEcCtD
Darifenacin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000586	0.00162	CcSEcCtD
Darifenacin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000585	0.00162	CcSEcCtD
Darifenacin—Syncope—Betamethasone—multiple sclerosis	0.000585	0.00162	CcSEcCtD
Darifenacin—Syncope—Dexamethasone—multiple sclerosis	0.000585	0.00162	CcSEcCtD
Darifenacin—Infection—Triamcinolone—multiple sclerosis	0.000583	0.00161	CcSEcCtD
Darifenacin—Sweating—Methotrexate—multiple sclerosis	0.000582	0.00161	CcSEcCtD
Darifenacin—Infection—Methylprednisolone—multiple sclerosis	0.000581	0.00161	CcSEcCtD
Darifenacin—Shock—Triamcinolone—multiple sclerosis	0.000577	0.0016	CcSEcCtD
Darifenacin—Insomnia—Prednisolone—multiple sclerosis	0.000577	0.0016	CcSEcCtD
Darifenacin—Shock—Methylprednisolone—multiple sclerosis	0.000576	0.00159	CcSEcCtD
Darifenacin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000574	0.00159	CcSEcCtD
Darifenacin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000573	0.00159	CcSEcCtD
Darifenacin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000573	0.00159	CcSEcCtD
Darifenacin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000573	0.00159	CcSEcCtD
Darifenacin—Tachycardia—Triamcinolone—multiple sclerosis	0.000572	0.00158	CcSEcCtD
Darifenacin—Mental disorder—Prednisone—multiple sclerosis	0.000571	0.00158	CcSEcCtD
Darifenacin—Nausea—Azathioprine—multiple sclerosis	0.000571	0.00158	CcSEcCtD
Darifenacin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000571	0.00158	CcSEcCtD
Darifenacin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000568	0.00157	CcSEcCtD
Darifenacin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000567	0.00157	CcSEcCtD
Darifenacin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000566	0.00157	CcSEcCtD
Darifenacin—Hypertension—Dexamethasone—multiple sclerosis	0.000563	0.00156	CcSEcCtD
Darifenacin—Hypertension—Betamethasone—multiple sclerosis	0.000563	0.00156	CcSEcCtD
Darifenacin—Asthenia—Mitoxantrone—multiple sclerosis	0.000558	0.00154	CcSEcCtD
Darifenacin—Pain—Prednisolone—multiple sclerosis	0.000545	0.00151	CcSEcCtD
Darifenacin—Pharyngitis—Methotrexate—multiple sclerosis	0.000541	0.0015	CcSEcCtD
Darifenacin—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000538	0.00149	CcSEcCtD
Darifenacin—Vision blurred—Prednisone—multiple sclerosis	0.000535	0.00148	CcSEcCtD
Darifenacin—Urethral disorder—Methotrexate—multiple sclerosis	0.000534	0.00148	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000534	0.00148	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000533	0.00148	CcSEcCtD
Darifenacin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000532	0.00147	CcSEcCtD
Darifenacin—Oedema—Dexamethasone—multiple sclerosis	0.000532	0.00147	CcSEcCtD
Darifenacin—Oedema—Betamethasone—multiple sclerosis	0.000532	0.00147	CcSEcCtD
Darifenacin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000532	0.00147	CcSEcCtD
Darifenacin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000532	0.00147	CcSEcCtD
Darifenacin—Insomnia—Triamcinolone—multiple sclerosis	0.00053	0.00147	CcSEcCtD
Darifenacin—Insomnia—Methylprednisolone—multiple sclerosis	0.000529	0.00147	CcSEcCtD
Darifenacin—Infection—Betamethasone—multiple sclerosis	0.000529	0.00146	CcSEcCtD
Darifenacin—Infection—Dexamethasone—multiple sclerosis	0.000529	0.00146	CcSEcCtD
Darifenacin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000525	0.00146	CcSEcCtD
Darifenacin—Visual impairment—Methotrexate—multiple sclerosis	0.000525	0.00145	CcSEcCtD
Darifenacin—Shock—Dexamethasone—multiple sclerosis	0.000523	0.00145	CcSEcCtD
Darifenacin—Shock—Betamethasone—multiple sclerosis	0.000523	0.00145	CcSEcCtD
Darifenacin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000523	0.00145	CcSEcCtD
Darifenacin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000522	0.00144	CcSEcCtD
Darifenacin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000522	0.00144	CcSEcCtD
Darifenacin—Tachycardia—Betamethasone—multiple sclerosis	0.000519	0.00144	CcSEcCtD
Darifenacin—Tachycardia—Dexamethasone—multiple sclerosis	0.000519	0.00144	CcSEcCtD
Darifenacin—Angioedema—Prednisone—multiple sclerosis	0.000519	0.00144	CcSEcCtD
Darifenacin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000516	0.00143	CcSEcCtD
Darifenacin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000515	0.00143	CcSEcCtD
Darifenacin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000515	0.00143	CcSEcCtD
Darifenacin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000514	0.00142	CcSEcCtD
Darifenacin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000514	0.00142	CcSEcCtD
Darifenacin—Eye disorder—Methotrexate—multiple sclerosis	0.000509	0.00141	CcSEcCtD
Darifenacin—Syncope—Prednisone—multiple sclerosis	0.000509	0.00141	CcSEcCtD
Darifenacin—Pain—Triamcinolone—multiple sclerosis	0.000501	0.00139	CcSEcCtD
Darifenacin—Loss of consciousness—Prednisone—multiple sclerosis	0.000499	0.00138	CcSEcCtD
Darifenacin—Angiopathy—Methotrexate—multiple sclerosis	0.000494	0.00137	CcSEcCtD
Darifenacin—Vomiting—Mitoxantrone—multiple sclerosis	0.000494	0.00137	CcSEcCtD
Darifenacin—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000491	0.00136	CcSEcCtD
Darifenacin—Hypertension—Prednisone—multiple sclerosis	0.00049	0.00136	CcSEcCtD
Darifenacin—Rash—Mitoxantrone—multiple sclerosis	0.00049	0.00136	CcSEcCtD
Darifenacin—Dermatitis—Mitoxantrone—multiple sclerosis	0.00049	0.00136	CcSEcCtD
Darifenacin—Headache—Mitoxantrone—multiple sclerosis	0.000487	0.00135	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000485	0.00134	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000485	0.00134	CcSEcCtD
Darifenacin—Arthralgia—Prednisone—multiple sclerosis	0.000483	0.00134	CcSEcCtD
Darifenacin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000483	0.00134	CcSEcCtD
Darifenacin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000482	0.00134	CcSEcCtD
Darifenacin—Insomnia—Betamethasone—multiple sclerosis	0.000481	0.00133	CcSEcCtD
Darifenacin—Insomnia—Dexamethasone—multiple sclerosis	0.000481	0.00133	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00048	0.00133	CcSEcCtD
Darifenacin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000478	0.00132	CcSEcCtD
Darifenacin—Mental disorder—Methotrexate—multiple sclerosis	0.000477	0.00132	CcSEcCtD
Darifenacin—Hypersensitivity—Prednisolone—multiple sclerosis	0.00047	0.0013	CcSEcCtD
Darifenacin—Dyspepsia—Betamethasone—multiple sclerosis	0.000468	0.0013	CcSEcCtD
Darifenacin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000468	0.0013	CcSEcCtD
Darifenacin—Dysgeusia—Methotrexate—multiple sclerosis	0.000465	0.00129	CcSEcCtD
Darifenacin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000463	0.00128	CcSEcCtD
Darifenacin—Oedema—Prednisone—multiple sclerosis	0.000463	0.00128	CcSEcCtD
Darifenacin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000462	0.00128	CcSEcCtD
Darifenacin—Nausea—Mitoxantrone—multiple sclerosis	0.000462	0.00128	CcSEcCtD
Darifenacin—Infection—Prednisone—multiple sclerosis	0.00046	0.00127	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000459	0.00127	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000459	0.00127	CcSEcCtD
Darifenacin—Back pain—Methotrexate—multiple sclerosis	0.000459	0.00127	CcSEcCtD
Darifenacin—Shock—Prednisone—multiple sclerosis	0.000456	0.00126	CcSEcCtD
Darifenacin—Pain—Betamethasone—multiple sclerosis	0.000455	0.00126	CcSEcCtD
Darifenacin—Pain—Dexamethasone—multiple sclerosis	0.000455	0.00126	CcSEcCtD
Darifenacin—Nervous system disorder—Prednisone—multiple sclerosis	0.000454	0.00126	CcSEcCtD
Darifenacin—Tachycardia—Prednisone—multiple sclerosis	0.000452	0.00125	CcSEcCtD
Darifenacin—Skin disorder—Prednisone—multiple sclerosis	0.00045	0.00125	CcSEcCtD
Darifenacin—Hyperhidrosis—Prednisone—multiple sclerosis	0.000448	0.00124	CcSEcCtD
Darifenacin—Vision blurred—Methotrexate—multiple sclerosis	0.000447	0.00124	CcSEcCtD
Darifenacin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000438	0.00121	CcSEcCtD
Darifenacin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000438	0.00121	CcSEcCtD
Darifenacin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000435	0.0012	CcSEcCtD
Darifenacin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000435	0.0012	CcSEcCtD
Darifenacin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000432	0.0012	CcSEcCtD
Darifenacin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000431	0.00119	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000422	0.00117	CcSEcCtD
Darifenacin—Dizziness—Prednisolone—multiple sclerosis	0.000422	0.00117	CcSEcCtD
Darifenacin—Asthenia—Triamcinolone—multiple sclerosis	0.000421	0.00117	CcSEcCtD
Darifenacin—Abdominal pain—Betamethasone—multiple sclerosis	0.000421	0.00116	CcSEcCtD
Darifenacin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000421	0.00116	CcSEcCtD
Darifenacin—Asthenia—Methylprednisolone—multiple sclerosis	0.00042	0.00116	CcSEcCtD
Darifenacin—Insomnia—Prednisone—multiple sclerosis	0.000419	0.00116	CcSEcCtD
Darifenacin—Pruritus—Triamcinolone—multiple sclerosis	0.000415	0.00115	CcSEcCtD
Darifenacin—Cough—Methotrexate—multiple sclerosis	0.000414	0.00115	CcSEcCtD
Darifenacin—Pruritus—Methylprednisolone—multiple sclerosis	0.000414	0.00115	CcSEcCtD
Darifenacin—Dyspepsia—Prednisone—multiple sclerosis	0.000408	0.00113	CcSEcCtD
Darifenacin—Arthralgia—Methotrexate—multiple sclerosis	0.000404	0.00112	CcSEcCtD
Darifenacin—Rash—Prednisolone—multiple sclerosis	0.000402	0.00111	CcSEcCtD
Darifenacin—Dermatitis—Prednisolone—multiple sclerosis	0.000402	0.00111	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000401	0.00111	CcSEcCtD
Darifenacin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.0004	0.00111	CcSEcCtD
Darifenacin—Headache—Prednisolone—multiple sclerosis	0.000399	0.00111	CcSEcCtD
Darifenacin—Constipation—Prednisone—multiple sclerosis	0.000396	0.0011	CcSEcCtD
Darifenacin—Confusional state—Methotrexate—multiple sclerosis	0.00039	0.00108	CcSEcCtD
Darifenacin—Dizziness—Triamcinolone—multiple sclerosis	0.000388	0.00107	CcSEcCtD
Darifenacin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000387	0.00107	CcSEcCtD
Darifenacin—Dizziness—Methylprednisolone—multiple sclerosis	0.000387	0.00107	CcSEcCtD
Darifenacin—Infection—Methotrexate—multiple sclerosis	0.000385	0.00107	CcSEcCtD
Darifenacin—Feeling abnormal—Prednisone—multiple sclerosis	0.000382	0.00106	CcSEcCtD
Darifenacin—Asthenia—Betamethasone—multiple sclerosis	0.000382	0.00106	CcSEcCtD
Darifenacin—Asthenia—Dexamethasone—multiple sclerosis	0.000382	0.00106	CcSEcCtD
Darifenacin—Nervous system disorder—Methotrexate—multiple sclerosis	0.00038	0.00105	CcSEcCtD
Darifenacin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000379	0.00105	CcSEcCtD
Darifenacin—Nausea—Prednisolone—multiple sclerosis	0.000379	0.00105	CcSEcCtD
Darifenacin—Pruritus—Dexamethasone—multiple sclerosis	0.000376	0.00104	CcSEcCtD
Darifenacin—Pruritus—Betamethasone—multiple sclerosis	0.000376	0.00104	CcSEcCtD
Darifenacin—Skin disorder—Methotrexate—multiple sclerosis	0.000376	0.00104	CcSEcCtD
Darifenacin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000374	0.00104	CcSEcCtD
Darifenacin—Vomiting—Triamcinolone—multiple sclerosis	0.000373	0.00103	CcSEcCtD
Darifenacin—Vomiting—Methylprednisolone—multiple sclerosis	0.000372	0.00103	CcSEcCtD
Darifenacin—Rash—Triamcinolone—multiple sclerosis	0.00037	0.00102	CcSEcCtD
Darifenacin—Dermatitis—Triamcinolone—multiple sclerosis	0.000369	0.00102	CcSEcCtD
Darifenacin—Rash—Methylprednisolone—multiple sclerosis	0.000369	0.00102	CcSEcCtD
Darifenacin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000369	0.00102	CcSEcCtD
Darifenacin—Headache—Triamcinolone—multiple sclerosis	0.000367	0.00102	CcSEcCtD
Darifenacin—Headache—Methylprednisolone—multiple sclerosis	0.000367	0.00102	CcSEcCtD
Darifenacin—Abdominal pain—Prednisone—multiple sclerosis	0.000366	0.00101	CcSEcCtD
Darifenacin—Diarrhoea—Betamethasone—multiple sclerosis	0.000364	0.00101	CcSEcCtD
Darifenacin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000364	0.00101	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000353	0.000977	CcSEcCtD
Darifenacin—Dizziness—Dexamethasone—multiple sclerosis	0.000352	0.000974	CcSEcCtD
Darifenacin—Dizziness—Betamethasone—multiple sclerosis	0.000352	0.000974	CcSEcCtD
Darifenacin—Insomnia—Methotrexate—multiple sclerosis	0.00035	0.00097	CcSEcCtD
Darifenacin—Nausea—Triamcinolone—multiple sclerosis	0.000348	0.000965	CcSEcCtD
Darifenacin—Nausea—Methylprednisolone—multiple sclerosis	0.000348	0.000962	CcSEcCtD
Darifenacin—Dyspnoea—Methotrexate—multiple sclerosis	0.000345	0.000956	CcSEcCtD
Darifenacin—Somnolence—Methotrexate—multiple sclerosis	0.000344	0.000953	CcSEcCtD
Darifenacin—Hypersensitivity—Prednisone—multiple sclerosis	0.000341	0.000945	CcSEcCtD
Darifenacin—Dyspepsia—Methotrexate—multiple sclerosis	0.000341	0.000944	CcSEcCtD
Darifenacin—Vomiting—Betamethasone—multiple sclerosis	0.000338	0.000937	CcSEcCtD
Darifenacin—Vomiting—Dexamethasone—multiple sclerosis	0.000338	0.000937	CcSEcCtD
Darifenacin—Rash—Betamethasone—multiple sclerosis	0.000335	0.000929	CcSEcCtD
Darifenacin—Rash—Dexamethasone—multiple sclerosis	0.000335	0.000929	CcSEcCtD
Darifenacin—Dermatitis—Betamethasone—multiple sclerosis	0.000335	0.000928	CcSEcCtD
Darifenacin—Dermatitis—Dexamethasone—multiple sclerosis	0.000335	0.000928	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000334	0.000926	CcSEcCtD
Darifenacin—Headache—Betamethasone—multiple sclerosis	0.000333	0.000923	CcSEcCtD
Darifenacin—Headache—Dexamethasone—multiple sclerosis	0.000333	0.000923	CcSEcCtD
Darifenacin—Asthenia—Prednisone—multiple sclerosis	0.000332	0.000921	CcSEcCtD
Darifenacin—Pain—Methotrexate—multiple sclerosis	0.000331	0.000917	CcSEcCtD
Darifenacin—Pruritus—Prednisone—multiple sclerosis	0.000328	0.000908	CcSEcCtD
Darifenacin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000319	0.000884	CcSEcCtD
Darifenacin—Diarrhoea—Prednisone—multiple sclerosis	0.000317	0.000878	CcSEcCtD
Darifenacin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000317	0.000877	CcSEcCtD
Darifenacin—Nausea—Betamethasone—multiple sclerosis	0.000316	0.000875	CcSEcCtD
Darifenacin—Nausea—Dexamethasone—multiple sclerosis	0.000316	0.000875	CcSEcCtD
Darifenacin—Dizziness—Prednisone—multiple sclerosis	0.000306	0.000849	CcSEcCtD
Darifenacin—Abdominal pain—Methotrexate—multiple sclerosis	0.000306	0.000848	CcSEcCtD
Darifenacin—Vomiting—Prednisone—multiple sclerosis	0.000295	0.000816	CcSEcCtD
Darifenacin—Rash—Prednisone—multiple sclerosis	0.000292	0.000809	CcSEcCtD
Darifenacin—Dermatitis—Prednisone—multiple sclerosis	0.000292	0.000808	CcSEcCtD
Darifenacin—Headache—Prednisone—multiple sclerosis	0.00029	0.000804	CcSEcCtD
Darifenacin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000285	0.00079	CcSEcCtD
Darifenacin—Asthenia—Methotrexate—multiple sclerosis	0.000278	0.000769	CcSEcCtD
Darifenacin—Nausea—Prednisone—multiple sclerosis	0.000275	0.000762	CcSEcCtD
Darifenacin—Pruritus—Methotrexate—multiple sclerosis	0.000274	0.000759	CcSEcCtD
Darifenacin—Diarrhoea—Methotrexate—multiple sclerosis	0.000265	0.000734	CcSEcCtD
Darifenacin—Dizziness—Methotrexate—multiple sclerosis	0.000256	0.000709	CcSEcCtD
Darifenacin—Vomiting—Methotrexate—multiple sclerosis	0.000246	0.000682	CcSEcCtD
Darifenacin—Rash—Methotrexate—multiple sclerosis	0.000244	0.000676	CcSEcCtD
Darifenacin—Dermatitis—Methotrexate—multiple sclerosis	0.000244	0.000676	CcSEcCtD
Darifenacin—Headache—Methotrexate—multiple sclerosis	0.000243	0.000672	CcSEcCtD
Darifenacin—Nausea—Methotrexate—multiple sclerosis	0.00023	0.000637	CcSEcCtD
Darifenacin—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	5.64e-05	0.000714	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	5.6e-05	0.000708	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CCL5—multiple sclerosis	5.6e-05	0.000707	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	5.59e-05	0.000707	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	5.58e-05	0.000705	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CCR5—multiple sclerosis	5.55e-05	0.000702	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	5.53e-05	0.000699	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	5.52e-05	0.000698	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	5.51e-05	0.000696	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	5.5e-05	0.000696	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	5.49e-05	0.000694	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—IL2RA—multiple sclerosis	5.47e-05	0.000692	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	5.45e-05	0.000689	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	5.44e-05	0.000687	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	5.42e-05	0.000685	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	5.41e-05	0.000683	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	5.4e-05	0.000683	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	5.39e-05	0.000681	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	5.34e-05	0.000675	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCL3—multiple sclerosis	5.34e-05	0.000675	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	5.32e-05	0.000672	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	5.29e-05	0.000669	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	5.27e-05	0.000666	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CCR5—multiple sclerosis	5.26e-05	0.000665	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	5.22e-05	0.00066	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	5.19e-05	0.000656	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	5.19e-05	0.000656	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL2RA—multiple sclerosis	5.19e-05	0.000656	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PTGER4—multiple sclerosis	5.14e-05	0.000649	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCL3—multiple sclerosis	5.11e-05	0.000646	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	5.08e-05	0.000643	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	5.07e-05	0.000641	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PGR—multiple sclerosis	5.06e-05	0.000639	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	5.05e-05	0.000638	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	5.05e-05	0.000638	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CCR5—multiple sclerosis	5.04e-05	0.000637	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	5.04e-05	0.000637	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	5.03e-05	0.000636	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	5.03e-05	0.000636	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	5.02e-05	0.000635	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	5.02e-05	0.000634	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	4.98e-05	0.00063	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	4.98e-05	0.00063	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	4.98e-05	0.000629	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL2RA—multiple sclerosis	4.97e-05	0.000628	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCR3—multiple sclerosis	4.96e-05	0.000627	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PTGER4—multiple sclerosis	4.92e-05	0.000622	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CD28—multiple sclerosis	4.91e-05	0.000621	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PGR—multiple sclerosis	4.84e-05	0.000612	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCR2—multiple sclerosis	4.83e-05	0.00061	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SRM—multiple sclerosis	4.82e-05	0.000609	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCR3—multiple sclerosis	4.75e-05	0.000601	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GPC5—multiple sclerosis	4.75e-05	0.0006	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CD28—multiple sclerosis	4.71e-05	0.000595	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCR2—multiple sclerosis	4.62e-05	0.000584	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	4.58e-05	0.000579	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	4.56e-05	0.000577	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—POMC—multiple sclerosis	4.53e-05	0.000573	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	4.52e-05	0.000571	CbGpPWpGaD
Darifenacin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.47e-05	0.000565	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CNR1—multiple sclerosis	4.45e-05	0.000563	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	4.4e-05	0.000556	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	4.34e-05	0.000548	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—POMC—multiple sclerosis	4.34e-05	0.000548	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	4.32e-05	0.000547	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	4.28e-05	0.000541	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CNR1—multiple sclerosis	4.26e-05	0.000539	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	4.17e-05	0.000527	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	4.15e-05	0.000525	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—POMC—multiple sclerosis	4.11e-05	0.00052	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CCL2—multiple sclerosis	4.03e-05	0.000509	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCL10—multiple sclerosis	4.01e-05	0.000507	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—POMC—multiple sclerosis	3.94e-05	0.000498	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	3.94e-05	0.000498	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.94e-05	0.000497	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	3.93e-05	0.000496	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	3.91e-05	0.000494	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	3.9e-05	0.000493	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	3.89e-05	0.000492	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	3.86e-05	0.000488	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CCL2—multiple sclerosis	3.85e-05	0.000487	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.85e-05	0.000487	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCL10—multiple sclerosis	3.84e-05	0.000485	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	3.84e-05	0.000485	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	3.8e-05	0.000481	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—BCHE—multiple sclerosis	3.78e-05	0.000478	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—TYK2—multiple sclerosis	3.66e-05	0.000462	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	3.6e-05	0.000455	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	3.59e-05	0.000453	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	3.55e-05	0.000449	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	3.55e-05	0.000449	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	3.54e-05	0.000447	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CD86—multiple sclerosis	3.51e-05	0.000443	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	3.5e-05	0.000443	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—TYK2—multiple sclerosis	3.5e-05	0.000442	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	3.5e-05	0.000442	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	3.49e-05	0.000441	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	3.46e-05	0.000438	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	3.45e-05	0.000437	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	3.45e-05	0.000436	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCL5—multiple sclerosis	3.45e-05	0.000436	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	3.42e-05	0.000432	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PGR—multiple sclerosis	3.41e-05	0.000431	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PGR—multiple sclerosis	3.4e-05	0.00043	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.39e-05	0.000429	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.39e-05	0.000429	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PGR—multiple sclerosis	3.37e-05	0.000426	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CD86—multiple sclerosis	3.36e-05	0.000424	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—IL2—multiple sclerosis	3.35e-05	0.000423	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	3.34e-05	0.000423	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	3.33e-05	0.000421	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CD28—multiple sclerosis	3.31e-05	0.000419	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCL5—multiple sclerosis	3.31e-05	0.000418	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CD28—multiple sclerosis	3.3e-05	0.000418	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	3.3e-05	0.000417	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CD28—multiple sclerosis	3.27e-05	0.000413	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	3.25e-05	0.000411	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	3.24e-05	0.00041	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	3.21e-05	0.000406	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—IL2—multiple sclerosis	3.21e-05	0.000405	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SPP1—multiple sclerosis	3.2e-05	0.000404	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCR5—multiple sclerosis	3.11e-05	0.000393	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.11e-05	0.000393	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL2RA—multiple sclerosis	3.06e-05	0.000387	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SPP1—multiple sclerosis	3.06e-05	0.000387	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	3.05e-05	0.000386	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	3.05e-05	0.000385	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL2—multiple sclerosis	3.04e-05	0.000384	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	3.02e-05	0.000381	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	3e-05	0.00038	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	2.99e-05	0.000378	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCR5—multiple sclerosis	2.98e-05	0.000376	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	2.96e-05	0.000375	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL2RA—multiple sclerosis	2.93e-05	0.000371	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL2—multiple sclerosis	2.91e-05	0.000368	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—APOE—multiple sclerosis	2.83e-05	0.000358	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	2.77e-05	0.000351	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	2.77e-05	0.00035	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	2.74e-05	0.000346	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	2.71e-05	0.000343	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—APOE—multiple sclerosis	2.71e-05	0.000342	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	2.71e-05	0.000342	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	2.7e-05	0.000342	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	2.7e-05	0.000341	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	2.68e-05	0.000339	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	2.67e-05	0.000337	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.57e-05	0.000325	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CD80—multiple sclerosis	2.56e-05	0.000323	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	2.46e-05	0.000312	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	2.46e-05	0.000311	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CD80—multiple sclerosis	2.45e-05	0.00031	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	2.43e-05	0.000308	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—POMC—multiple sclerosis	2.43e-05	0.000307	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCL2—multiple sclerosis	2.38e-05	0.000301	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CD86—multiple sclerosis	2.36e-05	0.000299	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CD86—multiple sclerosis	2.36e-05	0.000298	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CD86—multiple sclerosis	2.33e-05	0.000295	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—POMC—multiple sclerosis	2.33e-05	0.000294	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	2.33e-05	0.000294	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—MAPK1—multiple sclerosis	2.33e-05	0.000294	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	2.32e-05	0.000293	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	2.3e-05	0.00029	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCL2—multiple sclerosis	2.28e-05	0.000288	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—APOE—multiple sclerosis	2.27e-05	0.000287	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.26e-05	0.000286	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	2.26e-05	0.000285	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	2.25e-05	0.000285	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	2.23e-05	0.000282	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	2.23e-05	0.000282	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TYK2—multiple sclerosis	2.16e-05	0.000273	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	2.16e-05	0.000272	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	2.15e-05	0.000272	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	2.13e-05	0.000269	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	2.1e-05	0.000265	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	2.09e-05	0.000264	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	2.07e-05	0.000262	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	2.07e-05	0.000261	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	2.07e-05	0.000261	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	2.06e-05	0.00026	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	2.05e-05	0.000259	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	2.04e-05	0.000258	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	2.04e-05	0.000258	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	2.02e-05	0.000256	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—POMC—multiple sclerosis	1.95e-05	0.000247	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APOE—multiple sclerosis	1.91e-05	0.000241	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APOE—multiple sclerosis	1.9e-05	0.00024	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APOE—multiple sclerosis	1.88e-05	0.000238	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL2—multiple sclerosis	1.8e-05	0.000227	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	1.79e-05	0.000226	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ALB—multiple sclerosis	1.78e-05	0.000225	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CD80—multiple sclerosis	1.72e-05	0.000218	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL2—multiple sclerosis	1.72e-05	0.000218	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CD80—multiple sclerosis	1.72e-05	0.000217	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	1.71e-05	0.000216	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CD80—multiple sclerosis	1.7e-05	0.000215	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	1.7e-05	0.000215	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—POMC—multiple sclerosis	1.64e-05	0.000207	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—POMC—multiple sclerosis	1.63e-05	0.000206	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	1.63e-05	0.000206	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.62e-05	0.000204	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	1.6e-05	0.000203	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	1.6e-05	0.000202	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.58e-05	0.0002	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.57e-05	0.000198	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.56e-05	0.000198	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.55e-05	0.000196	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	1.51e-05	0.000191	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.48e-05	0.000187	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	1.46e-05	0.000184	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	1.45e-05	0.000183	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	1.45e-05	0.000183	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.44e-05	0.000182	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MYC—multiple sclerosis	1.4e-05	0.000178	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	1.4e-05	0.000177	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	1.37e-05	0.000174	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOE—multiple sclerosis	1.36e-05	0.000172	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MYC—multiple sclerosis	1.35e-05	0.00017	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	1.34e-05	0.00017	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	1.32e-05	0.000166	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL2—multiple sclerosis	1.21e-05	0.000153	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL2—multiple sclerosis	1.21e-05	0.000153	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	1.21e-05	0.000152	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	1.2e-05	0.000152	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL2—multiple sclerosis	1.2e-05	0.000151	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	1.19e-05	0.00015	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—POMC—multiple sclerosis	1.17e-05	0.000148	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	1.15e-05	0.000145	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	1.14e-05	0.000144	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	1.13e-05	0.000143	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ALB—multiple sclerosis	1.06e-05	0.000135	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6—multiple sclerosis	1.06e-05	0.000134	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	1.02e-05	0.000129	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	1.02e-05	0.000128	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6—multiple sclerosis	1.01e-05	0.000128	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	1.01e-05	0.000127	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MYC—multiple sclerosis	9.47e-06	0.00012	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	9.45e-06	0.000119	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MYC—multiple sclerosis	9.44e-06	0.000119	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	9.42e-06	0.000119	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MYC—multiple sclerosis	9.35e-06	0.000118	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	9.33e-06	0.000118	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	9.27e-06	0.000117	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	9.24e-06	0.000117	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	9.15e-06	0.000116	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOE—multiple sclerosis	8.89e-06	0.000112	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—POMC—multiple sclerosis	7.64e-06	9.65e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6—multiple sclerosis	7.12e-06	9e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6—multiple sclerosis	7.1e-06	8.97e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6—multiple sclerosis	7.03e-06	8.89e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALB—multiple sclerosis	6.96e-06	8.8e-05	CbGpPWpGaD
